Sylvester Comprehensive Cancer Center

E-mail a Friend

Joshua M. Hare, M.D.

General Information

Joshua M. Hare, M.D.

Languages

  • English

Certifications

  • American Board of Internal Med-Cardiovascular Disease

Specialties

  • Internal Medicine
  • Cardiovascular Disease - Internal Medicine

Roles

  • Director, Interdisciplinary Stem Cell Institute (ISCI)
  • Louis Lemberg Professor of Medicine

Research Interests

  1. The role of nitric oxide and oxidative stress in cardiovascular regulation
  2. The aging cardiovascular system
  3. Congestive heart failure, pathophysiology and therapy
  4. Stem cell applications for cardiovascular regeneration
  5. Genomics application in cardiovascular disease

Awards

Elected to Association of University Cardiologists
Elected to American Society of Clinical Investigation
Fellow
Paul Beeson Physician Faculty Scholar
Grant-in-aid
SmithKline Beecham Junior Faculty Award
Young Investigators Award
Clinical Investigator Development Award
Grant-in-Aid
Merck Scholar (declined)
Young Investigator Award
Trainee Investigator Award
Eli Lily Critical Care Cardiology Scholar
NIH Short-Term Research Training Grant
Cum Laude
B.A. with Honors in Biochemistry

Education

1994 Research Fellow
Harvard University
1994 Fellowship
The Brigham and Women's Hospital
1992 Program in Clinical Effectiveness
Harvard School of Public Health
1991 Residency
The Johns Hopkins Hospital
1991 Fellowship
Johns Hopkins University
1989 Internship
The Johns Hopkins Hospital
1988 M.D.
Johns Hopkins University School of Medicine
1984 B.A.
University of Pennsylvania

Publications

Biography

Areas of Specialization

  • Heart failure
  • Heart transplantation
  • Myocarditis
  • Cardiomyopathy
  • Stem cell therapy

Joshua Michael Hare, M.D., is chief of the Division of Cardiology, Louis Lemberg professor of medicine, professor of molecular and cellular pharmacology, and director of the Interdisciplinary Stem Cell Institute at the University of Miami Miller School of Medicine. Dr. Hare graduated from the University of Pennsylvania and has a medical degree from Johns Hopkins University. He did his residency at Hopkins and fellowships at Hopkins, Harvard University and The Brigham and Women's Hospital in Boston. Dr. Hare was Professor of Medicine and Biomedical Engineering and director of cardiac transplantation at Johns Hopkins, leading their heart failure program, before he joined the faculty at University of Miami.

Dr. Hare is one of the world's leading pioneers in the use of stem cell therapy to repair damaged hearts. He recently released findings on the first human clinical trial testing a stem-cell based treatment for heart attack patients, which showed the stem cell treated patients had lower rates of cardiac arrhythmias, and had significant improvements in heart, lung and symptom status. His work is widely published and has included recent articles in The New England Journal of Medicine, Nature, Proceedings of the National Academy of Sciences, Circulation, and Circulation Research. Dr. Hare is the principal investigator on a National Institutes of Health Specialized Center for Cell-Therapy (SCCT) funded stem cell study for patients with congestive heart failure.

E-mail a Friend